Report received of unspecified discrepant inratio values.Patient's therapeutic range 2.5 - 3.5.Patient self tester's daughter called requesting additional inratio test strips.The inratio product requested is being removed from the market (recall #z-2354 - z-2362-2016).No complaint allegations were made initially during the call.Patient had been transitioned to roche coaguchek.Although requested, it is unknown when the transition to coaguchek occurred.Therefore, any inr results provided may be from either the inratio system, roche system or potentially both systems.Patient's daughter stated her father was blind in one eye and the new coaguchek device was too small for him.Patient's daughter stated her father was currently in the hospital, due to fluctuating inr and cancer.Inr results were obtained from (b)(6) 2008 through (b)(6) 2016, however, it is unknown whether inratio or coaguchek was used.No comparative lab results were reported.There is no information available to confirm an adverse event and/or malfunction occurred or that the device caused or contributed to the reported event.With no laboratory inr results for comparison, it is unknown if discrepant results were received.Based on the inability to rule out the possibility that the device may have caused or contributed to the reported hospitalization and fluctuating inr results (unknown if inratio, roche or other device), this event is being conservatively reported as an adverse event based on the hospitalization potentially related to the patient's coagulation status; however a device deficiency cannot be substantiated.There was no additional information provided.
|